<DOC>
	<DOC>NCT01331902</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of nicorandil in the achievement of maximal coronary hyperemia compared with adenosine.</brief_summary>
	<brief_title>Comparison of Hyperemic Efficacy Between Nicorandil and Adenosine for Fractional Flow Reserve (FFR) Measurement</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Adenosine</mesh_term>
	<mesh_term>Nicorandil</mesh_term>
	<criteria>non infarct related, patients with moderate coronary artery stenosis normal left ventricular ejection fraction on echocardiogram infarctrelated arteries or clinically unstable state collateral blood flow to the target vessel is shown atrioventricular block on electrocardiogram reduced left ventricular ejection fraction (&lt;50%) or left ventricular hypertrophy on echocardiogram contraindication of adenosine bronchial asthma</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Adenosine</keyword>
	<keyword>Nicorandil</keyword>
	<keyword>Fractional Flow Reserve</keyword>
	<keyword>Maximal Hyperemia</keyword>
</DOC>